Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Early discharge criteria in patients with acute bacterial skin and skin structure infections in a large tertiary-care teaching hospital in Florence, Italy.

Lagi F, Ottino L, Mantengoli E, Distefano A, Corti G, Farese A, Dannaoui B, Ipponi A, Falai T, Rossolini GM, Bartoloni A, Bartalesi F.

Eur J Clin Microbiol Infect Dis. 2019 Jun 20. doi: 10.1007/s10096-019-03609-9. [Epub ahead of print]

PMID:
31222396
2.

Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections.

Tacconelli E, Cataldo MA, Mutters NT, Carrara E, Bartoloni A, Raglio A, Cauda R, Mantengoli E, Luzzaro F, Pan A, Beccara LA, Pecile P, Tinelli M, Rossolini GM.

Int J Antimicrob Agents. 2019 Jul;54(1):49-54. doi: 10.1016/j.ijantimicag.2019.04.007. Epub 2019 Apr 12.

PMID:
30986523
3.

Evaluation of a new rapid fluorescence immunoassay for the diagnosis of dengue and Zika virus infection.

Zammarchi L, Colao MG, Mantella A, Capobianco T, Mazzarelli G, Ciccone N, Tekle Kiros S, Mantengoli E, Rossolini GM, Bartoloni A.

J Clin Virol. 2019 Mar;112:34-39. doi: 10.1016/j.jcv.2019.01.011. Epub 2019 Jan 29.

PMID:
30738366
4.

Seroprevalence of West Nile and dengue virus in the human population of the Bolivian Chaco.

Bartoloni A, Remoli ME, Farchi F, Zammarchi L, Fortuna C, Benedetti E, Ciufolini MG, Macchioni F, Rojas P, Lara Y, Padilla C, Roselli M, Mantengoli E, Mantella A, Tolari F, Paredes GA, Monasterio J, Valdarchi C, Venturi G, Rezza G.

J Med Virol. 2019 Jan;91(1):146-150. doi: 10.1002/jmv.25283. Epub 2018 Sep 7.

PMID:
30118540
5.

Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period.

Mencarini J, Mantengoli E, Tofani L, Riccobono E, Fornaini R, Bartalesi F, Corti G, Farese A, Pecile P, Boni L, Rossolini GM, Bartoloni A.

Infection. 2018 Aug;46(4):469-476. doi: 10.1007/s15010-018-1139-z. Epub 2018 Apr 13.

PMID:
29654496
6.

The effect of merging two infectious disease units on hand hygiene adherence in Italy.

Petrilli CM, Mantengoli E, Saint S, Fowler KE, Bartoloni A.

J Infect Prev. 2017 May;18(3):144-147. doi: 10.1177/1757177416687830. Epub 2017 Feb 8.

7.

Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.

Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, Bartoloni A, Losito AR, Corcione S, Bartoletti M, Mantengoli E, Saffioti C, Pagani N, Tedeschi S, Spanu T, Rossolini GM, Marchese A, Ambretti S, Cauda R, Viale P, Viscoli C, Tumbarello M; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

Clin Microbiol Infect. 2015 Dec;21(12):1106.e1-8. doi: 10.1016/j.cmi.2015.08.001. Epub 2015 Aug 14.

8.

The effect of leadership on hand hygiene: assessing hand hygiene adherence prior to patient contact in 2 infectious disease units in Tuscany.

Lieber SR, Mantengoli E, Saint S, Fowler KE, Fumagalli C, Bartolozzi D, Magistri L, Niccolini F, Bartoloni A.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):313-6. doi: 10.1086/675296. Epub 2014 Jan 31.

PMID:
24521600
9.

Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.

Tinelli M, Cataldo MA, Mantengoli E, Cadeddu C, Cunietti E, Luzzaro F, Rossolini GM, Tacconelli E.

J Antimicrob Chemother. 2012 Dec;67(12):2982-7. doi: 10.1093/jac/dks300. Epub 2012 Aug 3.

PMID:
22865381
10.

Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection.

Bartalesi F, Veloci S, Baragli F, Mantengoli E, Guidi S, Bartolesi AM, Mannino R, Pecile P, Bartoloni A.

Infection. 2012 Jun;40(3):331-4. doi: 10.1007/s15010-011-0196-3. Epub 2011 Oct 18.

PMID:
22005933
11.

Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin.

Pallecchi L, Riccobono E, Montagnani F, Di Maggio T, Mantengoli E, Pollini S, Rossolini GM.

J Chemother. 2011 Oct;23(5):308-9. No abstract available.

PMID:
22005066
12.

Cellulitis caused by a methicillin-sensitive Staphylococcus aureus isolate harboring Panton-Valentine toxin in an American soldier returning from Iraq.

Tascini C, Tagliaferri E, Rossolini GM, Mantengoli E, Mirarchi G, Leonildi A, Polidori M, Menichetti F.

Int J Dermatol. 2011 Feb;50(2):206-7. doi: 10.1111/j.1365-4632.2010.04456.x. No abstract available.

PMID:
21244388
13.

Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.

Mantengoli E, Luzzaro F, Pecile P, Cecconi D, Cavallo A, Attala L, Bartoloni A, Rossolini GM.

Clin Infect Dis. 2011 Mar 1;52(5):690-1. doi: 10.1093/cid/ciq194. Epub 2011 Jan 10. No abstract available.

PMID:
21220769
14.

[In vitro synergism of ulifloxacin plus piperacillin/tazobactam against clinical isolates of Enterobacteriaceae producing extended-spectrum or AmpC-type β-lactamases].

Tascini C, Mantengoli E, Geminiani G, Leonildi A, Di Maggio T, Fondelli S, Rossolini GM, Tagiaferri E, Menichetti F.

Infez Med. 2010 Dec;18(4):243-7. Italian.

15.

Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents.

Rossolini GM, Mantengoli E, Montagnani F, Pollini S.

Curr Opin Microbiol. 2010 Oct;13(5):582-8. doi: 10.1016/j.mib.2010.08.006. Epub 2010 Sep 16. Review.

PMID:
20846900
16.

Double Synergy Differential Test for detection of plasmid-mediated AmpC-type beta-lactamases in Proteus mirabilis.

Sabia C, Sarti M, Mantengoli E, Gargiulo R, Mugnaioli C, Rossolini GM.

J Med Microbiol. 2010 Aug;59(Pt 8):998-1000. doi: 10.1099/jmm.0.020180-0. Epub 2010 May 27. No abstract available.

PMID:
20508001
17.

A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.

Pini A, Falciani C, Mantengoli E, Bindi S, Brunetti J, Iozzi S, Rossolini GM, Bracci L.

FASEB J. 2010 Apr;24(4):1015-22. doi: 10.1096/fj.09-145474. Epub 2009 Nov 16.

PMID:
19917670
18.

Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study.

Tacconelli E, De Angelis G, Cataldo MA, Mantengoli E, Spanu T, Pan A, Corti G, Radice A, Stolzuoli L, Antinori S, Paradisi F, Carosi G, Bernabei R, Antonelli M, Fadda G, Rossolini GM, Cauda R.

Antimicrob Agents Chemother. 2009 Oct;53(10):4264-9. doi: 10.1128/AAC.00431-09. Epub 2009 Aug 10.

19.

Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.

Luzzaro F, Brigante G, D'Andrea MM, Pini B, Giani T, Mantengoli E, Rossolini GM, Toniolo A.

Int J Antimicrob Agents. 2009 Apr;33(4):328-33. doi: 10.1016/j.ijantimicag.2008.09.007. Epub 2008 Dec 17.

PMID:
19095415
20.

Antimicrobial resistance in Europe and its potential impact on empirical therapy.

Rossolini GM, Mantengoli E.

Clin Microbiol Infect. 2008 Dec;14 Suppl 6:2-8. doi: 10.1111/j.1469-0691.2008.02126.x. Review.

21.

Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.

Rossolini GM, Mantengoli E, Docquier JD, Musmanno RA, Coratza G.

New Microbiol. 2007 Jul;30(3):332-9. Review.

22.

Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.

Endimiani A, Luzzaro F, Migliavacca R, Mantengoli E, Hujer AM, Hujer KM, Pagani L, Bonomo RA, Rossolini GM, Toniolo A.

Antimicrob Agents Chemother. 2007 Jun;51(6):2211-4. Epub 2007 Apr 2.

23.
24.

Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.

Rossolini GM, Mantengoli E.

Clin Microbiol Infect. 2005 Jul;11 Suppl 4:17-32. Review.

25.

Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy.

Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, Spalla M, Daturi R, Romero E, Rossolini GM.

J Clin Microbiol. 2004 Jun;42(6):2523-9.

26.

Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Luzzaro F, Mantengoli E, Perilli M, Lombardi G, Orlandi V, Orsatti A, Amicosante G, Rossolini GM, Toniolo A.

J Clin Microbiol. 2001 May;39(5):1865-70.

27.

PER-1 extended-spectrum beta-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy.

Pereira M, Perilli M, Mantengoli E, Luzzaro F, Toniolo A, Rossolini GM, Amicosante G.

Microb Drug Resist. 2000 Spring;6(1):85-90.

PMID:
10868812

Supplemental Content

Loading ...
Support Center